What is the recommended treatment approach for atrial septal defect in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Atrial Septal Defect in Pregnancy

Most pregnant women with isolated ASD tolerate pregnancy well with conservative medical management alone, and intervention during pregnancy is rarely indicated. 1

Risk Stratification and Initial Management

Pregnant women with ASD should be evaluated in a specialized Cardiology of Pregnancy (COP) clinic as early as possible for risk stratification and delivery planning 1. The key determinants of maternal and fetal risk include:

  • Shunt magnitude (Qp:Qs ratio)
  • Right heart chamber enlargement
  • Pulmonary artery pressures
  • Presence of symptoms (NYHA functional class)
  • Maternal oxygen saturation at rest and with exercise

Conservative Management (First-Line Approach)

For most pregnant women with ASD, medical management is the appropriate treatment strategy throughout pregnancy. This includes:

  • Beta-blockers (e.g., bisoprolol) for rate control if arrhythmias develop
  • Diuretics (e.g., furosemide) for volume management if symptomatic
  • Activity modification based on symptoms
  • Serial echocardiographic monitoring to assess right heart function and pulmonary pressures
  • Pulse oximetry at rest and with exercise to detect shunt reversal 2

The physiologic changes of pregnancy—including 40% increase in cardiac output and decreased systemic vascular resistance—are generally well-tolerated in pretricuspid shunts like ASD 3. The left-to-right shunt typically does not worsen significantly because both cardiac output and pulmonary blood flow increase proportionally.

Indications for Intervention During Pregnancy

Intervention during pregnancy should only be considered in the rare circumstance of severe, refractory symptoms despite optimal medical therapy. 4, 5

When to Consider Percutaneous or Surgical Closure:

Intervention may be warranted if:

  • Progressive NYHA class III-IV symptoms despite maximal medical therapy
  • Significant right heart failure with hemodynamic compromise
  • Severe pulmonary hypertension with evidence of maternal decompensation

Choice of Intervention:

If intervention is unavoidable, percutaneous device closure under transesophageal echocardiography (TEE) guidance without fluoroscopy is the preferred approach to avoid fetal radiation exposure 4, 5. This requires:

  • Secundum ASD with adequate septal rims for device placement
  • Experienced interventional team in a specialized center
  • TEE guidance throughout the procedure to eliminate radiation
  • Balloon-assisted technique may be needed for large defects (>30mm) 4

Surgical closure is reserved for:

  • Anatomically unsuitable defects for percutaneous closure (inadequate rims, very large defects >35mm)
  • Severe pulmonary hypertension requiring urgent intervention 6
  • Associated anomalies requiring surgical correction

Critical Contraindications

ASD closure must NOT be performed if:

  • Pulmonary artery systolic pressure >2/3 systemic pressure
  • Pulmonary vascular resistance >2/3 systemic resistance
  • Net right-to-left shunt present 2

These findings indicate Eisenmenger physiology, where closure would be harmful and potentially fatal.

Timing Considerations

Ideally, hemodynamically significant ASDs should be closed before pregnancy 7. Women with known ASD planning pregnancy should receive preconception counseling in a COP clinic, with consideration for elective closure if:

  • Qp:Qs ≥1.5:1 with right heart enlargement
  • History of paradoxical embolism
  • Symptomatic with exercise limitation

Studies show that surgical correction before pregnancy reduces miscarriage rates, preterm delivery, and maternal cardiac symptoms compared to pregnancy with uncorrected defects 7.

Delivery Planning

Vaginal delivery is preferred for most women with ASD unless obstetric indications necessitate cesarean section 1. The delivery plan should specify:

  • Hemodynamic monitoring during labor
  • Endocarditis prophylaxis is NOT routinely indicated for isolated ASD
  • Avoid excessive fluid administration to prevent volume overload
  • Second stage shortening with assisted delivery if symptomatic
  • Postpartum monitoring for 24-48 hours (highest risk period for decompensation)

Common Pitfalls to Avoid

  1. Do not assume all ASDs require closure during pregnancy—the vast majority are managed conservatively
  2. Do not perform closure in patients with elevated pulmonary vascular resistance without careful hemodynamic assessment
  3. Do not delay referral to specialized COP clinic if symptoms develop—early multidisciplinary involvement is critical 1
  4. Do not use fluoroscopy if intervention is needed—TEE-guided approaches eliminate fetal radiation exposure 4

Postpartum Management

Women remain at risk for cardiac decompensation in the immediate postpartum period due to autotransfusion from uterine involution. Continue cardiac monitoring for 24-48 hours postdelivery. Long-term cardiology follow-up should be arranged, with consideration for elective ASD closure after pregnancy if hemodynamically significant 1.

Related Questions

What are the principal types of atrial septal defect (ASD) based on anatomic location?
What is the appropriate management of an atrial septal defect (ASD) in the intensive care unit (ICU)?
What are the signs and symptoms of atrial septal defect (ASD)?
What is the appropriate management for a patient with an atrial septal defect (ASD) who also has a prolonged QT interval?
What is the recommended antibiotic prophylaxis (including dose, timing, and allergy alternatives) for percutaneous atrial septal defect (ASD) device closure?
Can febuxostat be used instead of allopurinol in a patient already on febuxostat with a serum uric acid of 9.8 mg/dL and a history of kidney stones?
Is it safe for a patient with type 2 diabetes and uncontrolled hypertension to purchase Ozempic (semaglutide) on the gray market?
What management steps should be taken for a 33-year-old woman with type 2 diabetes mellitus, BMI >34 kg/m², currently on glimepiride, metformin, empagliflozin, and tirzepatide (Mounjaro) titrated to 7.5 mg who continues to have excessive hunger and no weight loss despite stable glycemia?
What is the appropriate diazepam dose for a 3-year-old child to treat a seizure?
How should the basic metabolic panel, complete blood count, and abdominal x‑ray findings be interpreted and managed in an 83‑year‑old woman with recent explosive diarrhea episodes separated by a week, a period of constipation, mild abdominal discomfort, decreased oral intake, transverse myelitis with bladder dysfunction on prophylactic nitrofurantoin, and newly prescribed cholesterol‑lowering medication?
What is the appropriate treatment for recurrent urinary tract infections in a patient with chronic kidney disease stage 4?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.